Mettler-Toledo International (MTD) Stock Forecast & Price Target

$1,083.14 +41.24 (+3.96%)

As of 03:57 PM Eastern

Mettler-Toledo International - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 9 Analyst Ratings

Sell
1

Hold
5

Buy
3

Based on 9 Wall Street analysts who have issued ratings for Mettler-Toledo International in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 1 has given a sell rating, 5 have given a hold rating, and 3 have given a buy rating for MTD.

Consensus Price Target

$1,380.50
27.45% Upside

According to the 9 analysts' twelve-month price targets for Mettler-Toledo International, the average price target is $1,380.50. The highest price target for MTD is $1,475.00, while the lowest price target for MTD is $1,250.00. The average price target represents a forecasted upside of 27.45% from the current price of $1,083.14.

Get the Latest News and Ratings for MTD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Mettler-Toledo International and its competitors.

MTD Analyst Ratings Over Time

Type	Current Forecast 4/14/24 to 4/14/25	1 Month Ago 3/15/24 to 3/15/25	3 Months Ago 1/15/24 to 1/14/25	1 Year Ago 4/15/23 to 4/14/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	5 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$1,380.50	$1,380.50	$1,351.25	$1,233.25
Forecasted Upside	27.45% Upside	12.12% Upside	6.32% Upside	-2.21% Downside
Consensus Rating	Hold	Hold	Hold	Hold

Remove Ads

MTD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MTD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Mettler-Toledo International Stock vs. The Competition

Type	Mettler-Toledo International	Medical Companies	S&P 500
Consensus Rating Score	2.22	2.82	2.54
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	28.61% Upside	23,601.17% Upside	26.55% Upside
News Sentiment Rating	Positive News See Recent MTD News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/7/2025	Citigroup 2 of 5 stars	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$1,400.00 ➝ $1,400.00	+36.99%
2/10/2025	Evercore ISI 2 of 5 stars	V. Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$1,450.00 ➝ $1,475.00	+9.12%
2/10/2025	Wells Fargo & Company 3 of 5 stars	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$1,350.00 ➝ $1,400.00	+1.97%
2/10/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catherine Schulte Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$1,362.00 ➝ $1,369.00	-1.51%
12/13/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Schenkel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Peer Perform
11/11/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$1,550.00 ➝ $1,450.00	+13.50%
8/5/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$1,300.00 ➝ $1,400.00	+0.56%
7/9/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$1,150.00 ➝ $1,300.00	-1.41%
6/3/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold ➝ Underperform	$1,230.00 ➝ $1,250.00	-10.97%
5/8/2023	51job Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
Get the Latest News and Ratings for MTD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mettler-Toledo International and its competitors with MarketBeat's FREE daily newsletter.
5/7/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$1,650.00 ➝ $1,525.00	+7.02%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 04:54 PM ET.

Should I Buy Mettler-Toledo International Stock? MTD Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, April 6, 2025. Please send any questions or comments about these Mettler-Toledo International pros and cons to contact@marketbeat.com.

Mettler-Toledo International
Bull Case

Here are some ways that investors could benefit from investing in Mettler-Toledo International Inc.:

The company recently reported earnings per share (EPS) of $12.41, exceeding analysts' expectations of $11.76, indicating strong financial performance and potential for growth.
Mettler-Toledo International Inc. has a market capitalization of approximately $22.80 billion, reflecting its significant size and stability in the medical instruments sector.
The stock is currently trading at $1,094.01, which is below its 12-month high of $1,546.93, suggesting potential for price appreciation as it may recover towards its previous highs.
Institutional investors hold a substantial 95.07% of the company's stock, indicating strong confidence from large financial entities in the company's future prospects.
Recent upgrades from analysts, including target price increases from firms like Evercore ISI and Robert W. Baird, suggest positive sentiment and potential for stock price growth.

Mettler-Toledo International
Bear Case

Investors should be bearish about investing in Mettler-Toledo International Inc. for these reasons:

The stock has experienced a significant decline, trading down $78.49 recently, which may indicate volatility and potential risks for investors.
Insider selling activity, such as Gerry Keller's sale of 600 shares, which resulted in a 99.01% decrease in their ownership, could signal a lack of confidence in the company's short-term performance.
The company reported a negative return on equity of 591.54%, which suggests inefficiencies in generating profit from shareholders' equity, raising concerns about financial management.
Despite strong earnings, the stock's price-to-earnings (P/E) ratio of 26.99 is relatively high, which may indicate that the stock is overvalued compared to its earnings potential.
The stock's beta of 1.15 indicates that it is more volatile than the market, which could lead to larger price swings and increased risk for investors.

MTD Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Mettler-Toledo International is $1,380.50, with a high forecast of $1,475.00 and a low forecast of $1,250.00.
: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last twelve months. There is currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MTD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MTD, but not buy additional shares or sell existing shares.
: According to analysts, Mettler-Toledo International's stock has a predicted upside of 27.45% based on their 12-month stock forecasts.
: Over the previous 90 days, Mettler-Toledo International's stock had 1 upgrade by analysts.
: Mettler-Toledo International has been rated by research analysts at Citigroup, Evercore ISI, Robert W. Baird, and Wells Fargo & Company in the past 90 days.
: Analysts like Mettler-Toledo International less than other "medical" companies. The consensus rating for Mettler-Toledo International is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MTD compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MTD) was last updated on 4/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mettler-Toledo International (MTD) Stock Forecast & Price Target